Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Felipe Rey

1PUBLICATIONS

15CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 08, 2023

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.

Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh

Pageof 1

Frequent Collaborators

1 joint publications

Emmanuel S Antonarakis

1 joint publications

Se Hoon Park

1 joint publications

Jeffrey C Goh

1 joint publications

Jae Lyun Lee

1 joint publications

Niven Mehra

1 joint publications

Ray McDermott

1 joint publications

Peter C Fong

1 joint publications

Yi-Hsiu Huang

1 joint publications

Stephen D Begbie

1 joint publications

Rustem Airatovich Gafanov

Frequent Collaborators

1 joint publications

Emmanuel S Antonarakis

1 joint publications

Se Hoon Park

1 joint publications

Jeffrey C Goh

1 joint publications

Jae Lyun Lee

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

See more related videos